Personalized care in Radiation Oncology

During the first six years of its operations, RTsafe has focused mainly on brain cancer. PseudoPatient, nominated as one of the 100 most technologically significant products in 2019, is the personalized care solution that RTsafe has developed, patented and commercialized for brain tumor patients, following extensive R&D and tens of scientific publications. It is a 510k-FDA cleared solution that is already contributing to the safety and effectiveness of radiotherapy treatments globally – in a totally personalized way.

Our next core milestones are to make our personalized quality assurance solutions easily accessible to millions of cancer patients globally and to keep innovating and developing equivalent solutions for cancer types other than brain tumors.

At RTsafe, our goal is to develop and implement high-end technologies to achieve maximum treatment efficiency combined with maximum patient safety, allowing the patient to return to life’s activities, following an effective treatment.

Whatever role you play in the treatment cycle, RTsafe’s products and services can help you. Click on the button below to learn more about the benefits we can bring to you and your colleagues.

Find out how RTsafe can help you

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

The PseudoPatient® solution

Play Video

See what's new at RTsafe

RTsafe joins King’s College’s London Institute for Healthcare Engineering

RTsafe joins King’s College’s London Institute for Healthcare Engineering

Announcements
Athens, November 21, 2023 RTsafe, the Athens, Greece-based leader in personalised radiation therapy Quality Assurance, will be joining the London...
Read More
Webinar – Use of the RTsafe customized Spine anthropomorphic phantom during Stereotactic Body Radiation Therapy (SBRT) of spinal metastases implementation. Experience sharing

Webinar – Use of the RTsafe customized Spine anthropomorphic phantom during Stereotactic Body Radiation Therapy (SBRT) of spinal metastases implementation. Experience sharing

Webinars
Join our webinar on Tuesday, November 21 at 12:00 EET lead by Ahmed Hadj Henni, Medical Physicist (PhD) at Frédéric...
Read More
RTsafe and AEP Linac sign exclusive agreement for distribution

RTsafe and AEP Linac sign exclusive agreement for distribution

Announcements
ATHENS, Greece, October 12, 2023 RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for...
Read More

Testimonials

Download our complete
product cataloque.

Request a quote

End Users


Customers
ΕΣΠΑ Banner